Antigenic Shift and Increased Incidence of Meningococcal Disease
about
Prospects for vaccine prevention of meningococcal infectionWhole genome sequencing to investigate the emergence of clonal complex 23 Neisseria meningitidis serogroup Y disease in the United StatesProfile of serogroup Y meningococcal infections in Canada: Implications for vaccine selection.Epidemiological profile of meningococcal disease in the United StatesPopulation structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005Implications of differential age distribution of disease-associated meningococcal lineages for vaccine development.Molecular epidemiology of meningococcal disease in England and Wales 1975-1995, before the introduction of serogroup C conjugate vaccines.Persistence of hyperinvasive meningococcal strain types during global spread as recorded in the PubMLST database.A decade of invasive meningococcal disease surveillance in Poland.Geotemporal analysis of Neisseria meningitidis clones in the United States: 2000-2005.Optimization of Molecular Approaches to Genogroup Neisseria meningitidis Carriage Isolates and Implications for Monitoring the Impact of New Serogroup B VaccinesGenotypic and phenotypic characterization of carriage and invasive disease isolates of Neisseria meningitidis in FinlandDeletion of fetA gene sequences in serogroup B and C Neisseria meningitidis isolatesClonal distribution of invasive Neisseria meningitidis serogroup C strains circulating from 1976 to 2005 in greater Sao Paulo, Brazil.Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada.Spatiotemporal analysis of invasive meningococcal disease, Germany.Phenotypic and molecular characterization of invasive serogroup W135 Neisseria meningitidis strains from 1990 to 2005 in BrazilGenomic Epidemiology of Hypervirulent Serogroup W, ST-11 Neisseria meningitidisGenetic and antigenic analysis of invasive serogroup C Neisseria meningitidis in Canada: A decrease in the electrophoretic type (ET)-15 clonal type and an increase in the proportion of isolates belonging to the ET-37 (but not ET-15) clonal type duriPrevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccineDiversity of factor H-binding protein in Neisseria meningitidis carriage isolates.Phenotypic and molecular characterization of serogroup C Neisseria meningitidis associated with an outbreak in Bahia, BrazilState-based surveillance to determine trends in meningococcal disease.Population genomics: diversity and virulence in the Neisseria.Genotypic comparison of invasive Neisseria meningitidis serogroup Y isolates from the United States, South Africa, and Israel, isolated from 1999 through 2002.An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, July to August 2015.Expanding prevention of invasive meningococcal disease.New versus old meningococcal group B vaccines: how the new ones may benefit infants & toddlers.The epidemiology of meningococcal disease and the impact of vaccines.Epidemiology and meningococcal serogroup distribution in the United States.Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine.Neisseria meningitidis B vaccines.Controlling serogroup B invasive meningococcal disease: the Canadian perspective.Meningococcal vaccines: current issues and future strategies.The multicomponent meningococcal serogroup B vaccine (4CMenB): origin, composition, health impact and unknown aspects.Invasive meningococcal disease, Utah, 1995-2005.Genomic Analysis of Serogroup Y Neisseria meningitidis Isolates Reveals Extensive Similarities Between Carriage-Associated and Disease-Associated Organisms.Clinical presentation of invasive disease caused by Neisseria meningitidis serogroup Y in Sweden, 1995 to 2012.Genetic characterization of a Neisseria meningitidis cluster in Queensland, Australia.Comparative role of immunoglobulin A in protective immunity against the Bordetellae.
P2860
Q24537338-7F5A9607-ACA2-4D89-9DC2-FBCE391FB49EQ28730284-7EF55CB8-9304-4501-972A-B58DDB45173AQ33593690-D5126750-201F-4670-8C83-683C9FBC6F36Q33648635-8664D200-0233-4549-834F-180C3A59F3AEQ33729202-4346AD41-5922-4DD4-8939-0D53C41B7248Q33743483-61163973-1CF8-44E4-975E-2CDF3CE1C977Q33913048-85AC383F-5431-4F97-AED1-44A36EA69A84Q34428829-EBB660FD-4E3E-4C26-85C1-0F6AF6BC8988Q34972731-0A5F86C9-C645-409C-8BE0-299E9F99ED07Q35069945-1625292F-4E53-4620-A8A0-4AAF98FDC4FDQ35683382-B6766C09-5565-4A5E-8639-F6C8BE5F145CQ35689140-D8D3AFAF-96DA-467A-8222-40D14CF572ACQ35784238-AA25807E-2C6B-4E44-B825-C7EF2CDA762AQ35784362-121A19E6-4E71-40D6-9446-72E200BADCE4Q35913820-C54BD156-86C0-4697-ADED-E33E151E3AFEQ36023645-7F1B6501-E04A-4DD1-B630-E25CFA538241Q36244108-DD9DF77E-0569-43AE-ADB5-912AC9A62BD9Q36253028-5D49E539-6BFB-469A-8218-234EA7F3C8D4Q36333592-3D35D6AC-044F-464F-BB47-2C3F499C8399Q36464572-554E2036-683B-4140-9AEB-742731023A13Q36603664-F7308212-A4A8-45B5-8795-E9C7A81B5356Q36728528-AC0B6A3D-6AD9-4FBE-AA7D-3100AA160000Q37106468-4D41171F-EFAD-42CF-95AD-23CD37763E2DQ37281265-5C24732F-CBA7-4F45-A120-AAB9FE0E4123Q37333542-CA7C5182-CC82-4922-9156-99A1D0C92C36Q37485447-917C2752-49F4-4130-9D3C-62AC5B60F013Q37503239-2F2A9012-42F8-4439-9C44-FF02745EF195Q37690815-11B0F9C4-2729-4203-9193-979220C58047Q37706585-989FA783-4471-4018-B810-F993E32A8D5AQ37761235-6D75AF25-5D4A-4496-970F-91918AD532BAQ37798011-5E4A64D5-A5CE-4B89-B09F-50B347AD441AQ37932528-D5602FD1-CE3A-4192-AAAC-80A568F8B846Q38105338-79ECFDFE-E371-4AE9-9789-49388D162465Q38120493-59F60E78-BEFE-4A3A-A7A7-5CC820E726DDQ38599522-0EECFAD0-6D48-4704-99C8-E1887499CC11Q39254999-DA9FB9FA-3244-4905-A481-EE17DF385A7DQ40126952-9ECBF301-D4E8-4AB3-99B3-5CAA7D6BB435Q40212289-ADFA86E1-1DFC-4CCC-A258-0C57D766D918Q40220207-8B79F9CD-1B69-4A0C-BCA6-2B6415D4B3B8Q42413095-F078096C-7321-4974-B3E2-C2FCCA6B6243
P2860
Antigenic Shift and Increased Incidence of Meningococcal Disease
description
im März 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 28 March 2006
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2006
@uk
name
Antigenic Shift and Increased Incidence of Meningococcal Disease
@en
Antigenic Shift and Increased Incidence of Meningococcal Disease
@nl
type
label
Antigenic Shift and Increased Incidence of Meningococcal Disease
@en
Antigenic Shift and Increased Incidence of Meningococcal Disease
@nl
prefLabel
Antigenic Shift and Increased Incidence of Meningococcal Disease
@en
Antigenic Shift and Increased Incidence of Meningococcal Disease
@nl
P2093
P50
P356
P1476
Antigenic shift and increased incidence of meningococcal disease
@en
P2093
Jane W Marsh
Laurie Thomson Sanza
Lee H Harrison
Mary O'Leary
Maryland Emerging Infections Program
P304
P356
10.1086/501371
P407
P577
2006-03-28T00:00:00Z